Literature DB >> 10882626

The role of RANTES in meningococcal disease.

E D Carrol1, A P Thomson, K J Mobbs, C A Hart.   

Abstract

The chemokine RANTES (regulated on activation, normal T cell expressed and secreted) is a potent regulator of leukocyte trafficking. RANTES preferentially attracts mature CD4 cells as well as macrophages and eosinophils, but not neutrophils. In total, 128 children with meningococcal disease were prospectively studied, and the role of RANTES in the pathophysiology of meningococcal disease was assessed. Plasma RANTES, interleukin (IL)-8, IL-6, IL-1 receptor agonist, and tumor necrosis factor-alpha were measured at admission. Severity of disease was stratified by the Glasgow meningococcal septicemia prognostic score (GMSPS). RANTES levels correlated significantly with IL-8 levels, admission lactate levels, platelets, prothrombin time, and activated partial thromboplastin time. RANTES levels were lower in children with severe disease (GMSPS>/=8; P=.001), in those with septic shock (P<.0005), and in nonsurvivors (P=.048; Mann-Whitney test). RANTES is a potential mediator in the pathophysiology of meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882626     DOI: 10.1086/315680

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash.

Authors:  E D Carrol; P Newland; F A I Riordan; A P J Thomson; N Curtis; C A Hart
Journal:  Arch Dis Child       Date:  2002-04       Impact factor: 3.791

2.  Chemokine responses are increased in HIV-infected Malawian children with invasive pneumococcal disease.

Authors:  Enitan D Carrol; Limangeni A Mankhambo; Paul Balmer; Standwell Nkhoma; Daniel L Banda; Malcolm Guiver; Graham Jeffers; Nick Makwana; Elizabeth M Molyneux; Malcolm E Molyneux; Rosalind L Smyth; C Anthony Hart
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-01       Impact factor: 3.731

3.  A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis.

Authors:  Enitan D Carrol; Alistair P J Thomson; Ashley P Jones; Graham Jeffers; C Anthony Hart
Journal:  Intensive Care Med       Date:  2005-08-27       Impact factor: 17.440

4.  The amino acid sequence of Neisseria lactamica PorB surface-exposed loops influences Toll-like receptor 2-dependent cell activation.

Authors:  Deana N Toussi; Margaretha Carraway; Lee M Wetzler; Lisa A Lewis; Xiuping Liu; Paola Massari
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

5.  The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children.

Authors:  Limangeni A Mankhambo; Daniel L Banda; Graham Jeffers; Sarah A White; Paul Balmer; Standwell Nkhoma; Happy Phiri; Elizabeth M Molyneux; C Anthony Hart; Malcolm E Molyneux; Robert S Heyderman; Enitan D Carrol
Journal:  Crit Care       Date:  2010-05-21       Impact factor: 9.097

6.  CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity.

Authors:  Clementien L Vermont; Jan A Hazelzet; Ester D de Kleijn; Germie P J M van den Dobbelsteen; Ronald de Groot
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

7.  Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease.

Authors:  Petrus Jansen van Vuren; Sharon Shalekoff; Antoinette A Grobbelaar; Brett N Archer; Juno Thomas; Caroline T Tiemessen; Janusz T Paweska
Journal:  Virol J       Date:  2015-10-06       Impact factor: 4.099

8.  Prediction of disease severity in young children presenting with acute febrile illness in resource-limited settings: a protocol for a prospective observational study.

Authors:  Sakib Burza; Yoel Lubell; Arjun Chandna; Endashaw M Aderie; Riris Ahmad; Eggi Arguni; Elizabeth A Ashley; Tanya Cope; Vu Quoc Dat; Nicholas P J Day; Arjen M Dondorp; Victor Illanes; Joanne De Jesus; Carolina Jimenez; Kevin Kain; Keang Suy; Constantinos Koshiaris; Estrella Lasry; Mayfong Mayxay; Dinesh Mondal; Rafael Perera; Tiengkham Pongvongsa; Sayaphet Rattanavong; Michael Rekart; Melissa Richard-Greenblatt; Mohammad Shomik; Phouthalavanh Souvannasing; Veronica Tallo; Claudia Turner; Paul Turner; Naomi Waithira; James A Watson; Mikhael Yosia
Journal:  BMJ Open       Date:  2021-01-25       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.